Zydus Lifesciences Limited (ZYDUSLIFE) — Strategic Asset Allocation Index
Zydus Lifesciences Limited (ZYDUSLIFE) has a Strategic Asset Allocation Index of 35.8% as of September 2022. Strategic assets (PP&E of Rs67.22 Billion plus long-term investments of Rs-) total Rs67.22 Billion, measured against net assets of Rs187.68 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Zydus Lifesciences Limited balance sheet quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Zydus Lifesciences Limited Strategic Asset Allocation Index (2020–2022)
This chart shows how Zydus Lifesciences Limited's Strategic Asset Allocation Index has evolved across 3 annual periods from 2020 to 2022. As of September 2022, the index stands at 35.8%, representing strategic assets of Rs67.22 Billion against net assets of Rs187.68 Billion INR. For live market cap and overall valuation, see Zydus Lifesciences Limited (ZYDUSLIFE) market capitalisation.
Annual Strategic Asset Allocation Index for Zydus Lifesciences Limited (2020–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Zydus Lifesciences Limited from 2020 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See what is Zydus Lifesciences Limited's book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (INR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 33.7% | Rs64.23 Billion | Rs64.23 Billion | Rs- | Rs190.54 Billion | ▼ -8.7 pp |
| 2021 | 42.4% | Rs63.33 Billion | Rs63.33 Billion | Rs- | Rs149.30 Billion | ▼ -10.5 pp |
| 2020 | 52.9% | Rs61.94 Billion | Rs61.94 Billion | Rs- | Rs117.10 Billion | — |